Cargando…

Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies

OBJECTIVE: Current non-invasive early detection of colorectal cancer (CRC) requires improvement. We aimed to identified a fecal Clostridium symbiosum-based biomarker for early and advanced colorectal cancer detection. DESIGN: In the test stage, the relative abundance of Clostridium symbiosum (C. sym...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Yuan-Hong, Gao, Qin-Yan, Cai, Guo-Xiang, Sun, Xiao-Ming, Zou, Tian-Hui, Chen, Hui-Min, Yu, Si-Yi, Qiu, Yi-Wen, Gu, Wei-Qi, Chen, Xiao-Yu, Cui, Yun, Sun, Danfeng, Liu, Zhan-Ju, Cai, San-Jun, Xu, Jie, Chen, Ying-Xuan, Fang, Jing-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704049/ https://www.ncbi.nlm.nih.gov/pubmed/29033369 http://dx.doi.org/10.1016/j.ebiom.2017.10.005

Ejemplares similares

Corrigendum to “Fecal Clostridium Symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies” [Ebiomedicine 25 (2017) 32–40]
por: Xie, Yuan-Hong, et al.
Publicado: (2018)

Enhanced glucose homeostasis via Clostridium symbiosum-mediated glucagon-like peptide 1 inhibition of hepatic gluconeogenesis in mid-intestinal bypass surgery
por: Luo, Xin, et al.
Publicado: (2023)

Molecular and Low-Resolution Structural Characterization of the Na(+)-Translocating Glutaconyl-CoA Decarboxylase From Clostridium symbiosum
por: Vitt, Stella, et al.
Publicado: (2020)

Fecal Host Transcriptomics for Noninvasive Mucosal Immune Profiling in Human Clostridium difficile Infection
por: Schlaberg, Robert, et al.
Publicado: (2017)

Fecal Enterotoxigenic Bacteroides fragilis–Peptostreptococcus stomatis–Parvimonas micra Biomarker for Noninvasive Diagnosis and Prognosis of Colorectal Laterally Spreading Tumor
por: Shen, Xiaonan, et al.
Publicado: (2021)

Clinical Efficacy and Microbiome Changes Following Fecal Microbiota Transplantation in Children With Recurrent Clostridium Difficile Infection
por: Li, Xiaolu, et al.
Publicado: (2018)

Influence of the microbiota on epigenetics in colorectal cancer
por: Sun, Danfeng, et al.
Publicado: (2019)

Microbiome in Intestinal Lavage Fluid May Be A Better Indicator in Evaluating The Risk of Developing Colorectal Cancer Compared with Fecal Samples
por: Shen, Weitao, et al.
Publicado: (2020)

The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial
por: Sun, Yi-Yuan, et al.
Publicado: (2018)

The Role of Fecal Fusobacterium nucleatum and pks(+) Escherichia coli as Early Diagnostic Markers of Colorectal Cancer
por: Liu, Kaixi, et al.
Publicado: (2021)

Noninvasive urinary protein signatures associated with colorectal cancer diagnosis and metastasis
por: Sun, Yulin, et al.
Publicado: (2022)

Fecal Bacteria as Non-Invasive Biomarkers for Colorectal Adenocarcinoma
por: Yuan, Biao, et al.
Publicado: (2021)

Fecal Calprotectin Level Reflects the Severity of Clostridium difficile Infection
por: Kim, Jieun, et al.
Publicado: (2017)

Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease
por: Wang, Xinqiong, et al.
Publicado: (2021)

FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
por: Lu, Xiao-Jie, et al.
Publicado: (2020)

Clostridium difficile colonization in preoperative colorectal cancer patients
por: Zheng, Yi, et al.
Publicado: (2017)

Cost-Effectiveness between Double and Single Fecal Immunochemical Test(s) in a Mass Colorectal Cancer Screening
por: Cai, Shan-Rong, et al.
Publicado: (2016)

Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test
por: He, Xu-xia, et al.
Publicado: (2019)

Genome-Wide Analysis Reveals Hypoxic Microenvironment Is Associated With Immunosuppression in Poor Survival of Stage II/III Colorectal Cancer Patients
por: Chen, Yu-feng, et al.
Publicado: (2021)

Risk Factors of Fecal Toxigenic or Non-Toxigenic Clostridium difficile Colonization: Impact of Toll-Like Receptor Polymorphisms and Prior Antibiotic Exposure
por: Hung, Yuan-Pin, et al.
Publicado: (2013)

Fecal Microbiota Transplantation Ameliorates Active Ulcerative Colitis by Downregulating Pro-inflammatory Cytokines in Mucosa and Serum
por: Zhang, Wen-Hui, et al.
Publicado: (2022)

Fecal Transplantation for the Treatment of Recurrent Clostridium Difficile Infection
por: Karadsheh, Zeid, et al.
Publicado: (2013)

Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
por: Hussam, Dina, et al.
Publicado: (2017)

Novel noninvasive quantification of penile corpus cavernosum lesions in hyperlipidemia-induced erectile dysfunction in rabbits by two-dimensional shear-wave elastography
por: Hu, Jian-Lin, et al.
Publicado: (2019)

Germline mutations in a DNA repair pathway are associated with familial colorectal cancer
por: Xu, Pingping, et al.
Publicado: (2021)

Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations
por: Sinha, Rashmi, et al.
Publicado: (2016)

Performance of the Fecal Immunochemical Test in Detecting Advanced Colorectal Neoplasms and Colorectal Cancers in People Aged 40–49 Years: A Systematic Review and Meta-Analysis
por: Yeh, Jen-Hao, et al.
Publicado: (2023)

Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer
por: Yao, Qiulin, et al.
Publicado: (2021)

Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
por: Yi, You-Cai, et al.
Publicado: (2021)

Clinical evaluation of a multitarget fecal immunochemical test‐sDNA test for colorectal cancer screening in a high‐risk population: a prospective, multicenter clinical study
por: Hu, Ye‐Ting, et al.
Publicado: (2023)

Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis
por: Mo, Shaobo, et al.
Publicado: (2021)

Glutamine as a Potential Noninvasive Biomarker for Human Embryo Selection
por: Miao, Sui-Bing, et al.
Publicado: (2022)

Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance
por: Park, Leslie, et al.
Publicado: (2017)

The protective effects of dietary Clostridium butyricum supplementation on hepatic ischemia reperfusion injury in rats
por: Yang, Xuan, et al.
Publicado: (2022)

The influence of food processing methods on serum parameters, apparent total-tract macronutrient digestibility, fecal microbiota and SCFA content in adult beagles
por: Cai, Xuan, et al.
Publicado: (2022)

DNA hypomethylation of CBS promoter induced by folate deficiency is a potential noninvasive circulating biomarker for colorectal adenocarcinomas
por: Xue, Geng, et al.
Publicado: (2017)

Systematic evaluation of supervised classifiers for fecal microbiota-based prediction of colorectal cancer
por: Ai, Luoyan, et al.
Publicado: (2017)

Alteration of fecal tryptophan metabolism correlates with shifted microbiota and may be involved in pathogenesis of colorectal cancer
por: Sun, Xi-Zhen, et al.
Publicado: (2020)

Noninvasive Assessment of Response to Neoadjuvant Chemotherapy in Osteosarcoma of Long Bones with Diffusion-Weighted Imaging: An Initial In Vivo Study
por: Wang, Cheng-Sheng, et al.
Publicado: (2013)

A reporter for noninvasively monitoring gene expression and plant transformation
por: He, Yubing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bs05pdk0tvfgcdm0hto9r9tm1q